Total Funding
53
92
Total FundingSeed raised
Growth Score
-2 pts
Heat Score
90 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
112890
Syntara develops clinical-stage medicines targeting blood cancers, fibrosis, and inflammation using amine oxidase chemistry.
About the Company
Syntara is a clinical-stage biotechnology company focused on developing therapies for blood cancers and diseases associated with inflammation and fibrosis. It researches and develops drug candidates targeting conditions such as myelofibrosis, myelodysplastic syndrome, and various fibrotic diseases. The company uses amine oxidase chemistry and
related technologies to address extracellular matrix dysfunction in multiple disease areas. Its pipeline includes treatments for skin scarring, neuroinflammation, and other chronic conditions under clinical development.
